Javad Kojuri
Overview
Explore the profile of Javad Kojuri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
491
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hassani A, Kamran H, Kojuri J, Bazroodi H, Fatemian H, Rasekhi A, et al.
Urol Case Rep
. 2024 Dec;
58:102891.
PMID: 39668976
Ureteral stent migration should be considered a rare complication of urologic procedures. We report a 69-year-old woman diagnosed with ureteral stent migration two weeks after undergoing percutaneous nephrolithotomy while she...
2.
Golchin Vafa R, Molavi Vardanjani H, Kojuri J
Vascul Pharmacol
. 2024 Nov;
157:107441.
PMID: 39581248
Background: Post-percutaneous coronary intervention (PCI) patients often require complex medication regimens to prevent adverse cardiovascular events. However, these regimens can lead to potential drug-drug interactions (pDDIs) and polypharmacy, posing significant...
3.
Sarrafzadegan N, Bagherikholenjani F, Shahidi S, Ghasemi G, Shirvani E, Rajati F, et al.
J Res Med Sci
. 2024 Sep;
29:32.
PMID: 39239072
Background: This article introduces the first national guidelines for the management including diagnosis, treatment, and secondary prevention of acute coronary syndrome (ACS) in Iran. Materials And Methods: The members of...
4.
Golchin Vafa R, Hosseini N, Montaseri M, Kojuri J
Am J Case Rep
. 2024 Jul;
25:e944099.
PMID: 39069697
BACKGROUND Cerebrovascular occlusion is a critical health concern associated with strokes, a leading cause of mortality worldwide. Large vessel occlusion, constituting a significant portion of acute ischemic strokes, presents serious...
5.
Bagheri Kholenjani F, Shahidi S, Vaseghi G, Ashoorion V, Sarrafzadegan N, Siavash M, et al.
J Res Med Sci
. 2024 May;
29:18.
PMID: 38808220
This guideline is the first Iranian guideline developed for the diagnosis, management, and treatment of hyperlipidemia in adults. The members of the guideline developing group (GDG) selected 9 relevant clinical...
6.
Azami P, Golchin Vafa R, Heydarzadeh R, Sadeghi M, Amiri F, Azadian A, et al.
BMC Cardiovasc Disord
. 2024 May;
24(1):240.
PMID: 38714940
Background: Coronavirus disease 2019 (COVID-19) has various sequelae, one of which might be hypertension. We aimed to evaluate COVID-19's impact on blood pressure (BP) in non-hospitalized patients at one-year follow-up....
7.
Attar A, Kouhanjani M, Hessami K, Vosough M, Kojuri J, Ramzi M, et al.
Stem Cell Res Ther
. 2024 Feb;
15(1):40.
PMID: 38355635
No abstract available.
8.
Anaraki K, Zahed Z, Javid R, Shafiei S, Beiranvandi F, Ghasemi Kahrizsangi N, et al.
Vascul Pharmacol
. 2024 Feb;
154:107283.
PMID: 38340884
Aortic valve stenosis is the most common type of heart valve disease in the United States and Europe and calcific aortic stenosis (AS) affects 2-7% of people aged 65 years...
9.
Mehdizadeh Parizi M, Golchin Vafa R, Ahmadi A, Heydarzade R, Sadeghi M, Khademolhossseini A, et al.
J Interv Cardiol
. 2024 Jan;
2023:5544440.
PMID: 38170033
Background: Dual antiplatelet therapy with a P2Y12 inhibitor (e.g., clopidogrel and ticagrelor) and aspirin is recommended for at least one year after percutaneous coronary intervention (PCI) to prevent further myocardial...
10.
Kojuri J, Rahmani M, Golchin Vafa R, Ahmadi A, Mehdizadeh M, Heidar Alizadeh R, et al.
MedEdPublish (2016)
. 2023 Dec;
8:15.
PMID: 38089384
This article was migrated. The article was marked as recommended.